Company profile
Quarry Thera
The future of induced proximity therapeutics.
- Industry
- Biotechnology Research
- Employees
- 22
Quarry Thera company summary
Quarry Thera is a company in the Biotechnology Research industry. On LinkedIn the company has around 22 employees.
What technology does Quarry Thera use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Quarry Thera
Quarry Thera is building the next generation of induced proximity therapeutics, engineering oral small molecules to unlock novel pharmacology in immunology and oncology. We bring proteins together to create functional outcomes that go beyond inhibition or target removal, opening new possibilities for how medicines work inside the cell. Our platform advances two complementary modalities, molecular glues and heterobifunctionals, applying the right chemistry to the right biology. Across immunology and oncology, we focus on oral delivery as a path to better pharmacology, broader applicability, and medicines built for long-term use. Founded by Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer and President of Worldwide R&D at Pfizer, and Craig Crews, Ph.D., pioneer of proximity-based therapeutics and Professor at Yale University, Quarry carries that experience forward, grounded in the conviction that the most important advances in proximity-based medicine are still ahead.
Compare companies similar to Quarry Thera
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Quarry Thera quarrythera.com | Biotechnology Research | 22 | - | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Quarry Thera
What does Quarry Thera do?
Quarry Thera is building the next generation of induced proximity therapeutics, engineering oral small molecules to unlock novel pharmacology in immunology and oncology. We bring proteins together to create functional outcomes that go beyond inhibition or target removal, opening new possibilities for how medicines work inside the cell. Our platform advances two complementary modalities, molecular glues and heterobifunctionals, applying the right chemistry to the right biology. Across immunology and oncology, we focus on oral delivery as a path to better pharmacology, broader applicability, and medicines built for long-term use. Founded by Mikael Dolsten, M.D., Ph.D., former Chief Scientific Officer and President of Worldwide R&D at Pfizer, and Craig Crews, Ph.D., pioneer of proximity-based therapeutics and Professor at Yale University, Quarry carries that experience forward, grounded in the conviction that the most important advances in proximity-based medicine are still ahead.
How many employees does Quarry Thera have?
Quarry Thera has around 22 employees on LinkedIn.
Build a lead list from companies like Quarry Thera
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.